A study of nearly 28,000 23andMe users who reported taking GLP-1 weight-loss medications, published in Nature, found that a mutation in GLP1R, the gene encoding the protein targeted by GLP-1 drugs, was modestly but significantly associated with greater weight loss
True medication failure presents as loss of all subjective effects: appetite suppression gone, food noise returned, portion sizes increased, and characteristic medication sensations absent
Neurotransmitters and glucagon release from the isolated, perfused canine stomach
Case Example: A prostate cancer patient used alternating Curcumin and Vitamin C infusions alongside integrative therapies, achieving stable disease control
Honest answers
Roux-en-Y gastric bypass contributes to weight loss-independent improvement in hypothalamic inflammation and leptin sensitivity through gut-microglia-neuron-crosstalk